Form 4 for REPL Replimune Group, Inc.
Accepted 2023-04-04 00:00:00 ET · period of report 2023-04-01 · accession 0001104659-23-041727 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-04 | 2023-04-01 | REPL | Esposito Pamela | Chief Business Off | A - Grant | $0.00 | +40.0K | 269.4K | +17% | $0 |
| D | 2023-04-04 | 2023-04-01 | REPL | Esposito Pamela | Chief Business Off | A - Grant | $0.00 | +60.0K | 60.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-01 | A | A | 40,000 | $0.00 | 269,402 | D | — | — | (F1) Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-04-01 | A | A | 60,000 | $0.00 | 60,000 | D | $17.66 · — to 2033-04-01 | 60,000 Common Stock | (F2) 25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. |